Filing Details
- Accession Number:
- 0000899243-19-003537
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-13 21:38:12
- Reporting Period:
- 2019-02-12
- Accepted Time:
- 2019-02-13 21:38:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1217234 | Caredx Inc. | CDNA | Services-Medical Laboratories (8071) | 943316839 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1421336 | P James Yee | C/O Caredx, Inc. 3260 Bayshore Boulevard Brisbane CA 94005 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-12 | 3,649 | $3.70 | 73,543 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-02-12 | 3,649 | $3.97 | 77,192 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-12 | 32,500 | $23.88 | 44,692 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to Purchase Common Stock | Disposition | 2019-02-12 | 3,649 | $0.00 | 3,649 | $3.70 |
| Common Stock | Option to Purchase Common Stock | Disposition | 2019-02-12 | 3,649 | $0.00 | 3,649 | $3.97 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-04-08 | No | 4 | M | Direct | |
| 0 | 2020-08-27 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2018.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.68 to $24.24, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
- Immediately.
Billionaire Hedge Funds
